David Hodgson, MD
General Practice · Washington, KSNPI 1902807522
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (57.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Smiths Medical ASD, Inc. accounts for 97.7% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $6,112 and has fallen 98.7% since, to $82 in 2025. Among general practice clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 36 payments — averaging $511.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smiths Medical ASD, Inc.$18K
- AstraZeneca$106
- AbbVie$83
- Vapotherm Inc$58
- Mylan Specialty L.p.$50
- Amgen$29
- plus $96 from 6 others
What the payments were for
- Royalty or licence$10,50057%
- Consulting fees$7,50041%
- Food & beverage$4222%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smiths Medical ASD, Inc. | 12 | $18,000 |
| AstraZeneca | 7 | $106 |
| AbbVie | 4 | $83 |
| Vapotherm Inc | 2 | $58 |
| Mylan Specialty L.p. | 3 | $50 |
| Amgen | 2 | $29 |
| Baxter Healthcare | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Pfizer | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Organogenesis Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
How this compares
$18,422 in reported general payments places this provider in the 95th percentile of 771 general practice providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 63 | $48,872 |
| OzempicSemaglutide | 28 | $26,017 |
| JanuviaSitagliptin Phosphate | 16 | $14,095 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $10,223 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 19 | $5,874 |
| Metoprolol Succinate | 337 | $4,692 |
| Atorvastatin Calcium | 401 | $4,566 |
| Levothyroxine Sodium | 336 | $3,926 |
| Duloxetine Hcl | 87 | $3,826 |
| PremproEstrogen,con/M-Progest Acet | 13 | $3,089 |
| Tamsulosin Hcl | 212 | $3,033 |
| Rosuvastatin Calcium | 167 | $2,943 |
| Pantoprazole Sodium | 285 | $2,928 |
| Gabapentin | 129 | $2,894 |
| Dexlansoprazole DrDexlansoprazole | 12 | $2,863 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Abrysvo, Prempro, Premarin | $16 | $60,444107 claims |
| AbbVieSynthroid | $83 | $1,52629 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 771 general practice providers in Kansas.
Other general practice in Washington
- Patrick LillisOverland Park$326K
- Douglas SchulzOverland Park$98K
- Grant SmithPrairie Village$28K
- John AdamsSalina$15K
- Ryan BucherOlathe$14K
- Stephen HuberLeawood$14K
- Nancy AddyLeawood$13K
- Guy GrossSalina$13K
- Molly ReynoldsCherryvale$11K
- Aubrey RalstonEl Dorado$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.